| Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis AJ Van Der Meer, BJ Veldt, JJ Feld, H Wedemeyer, JF Dufour, F Lammert, ... Jama 308 (24), 2584-2593, 2012 | 1863 | 2012 |
| Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial HLA Janssen, M van Zonneveld, H Senturk, S Zeuzem, US Akarca, ... The Lancet 365 (9454), 123-129, 2005 | 1567 | 2005 |
| A placebo-controlled trial of obeticholic acid in primary biliary cholangitis F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ... New England Journal of Medicine 375 (7), 631-643, 2016 | 1099 | 2016 |
| Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis BJ Veldt, EJ Heathcote, H Wedemeyer, J Reichen, WP Hofmann, ... Annals of internal medicine 147 (10), 677-684, 2007 | 875 | 2007 |
| Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid EMM Kuiper, BE Hansen, RA de Vries, JW den Ouden–Muller, ... Gastroenterology 136 (4), 1281-1287, 2009 | 518 | 2009 |
| Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy GV Papatheodoridis, HLY Chan, BE Hansen, HLA Janssen, P Lampertico Journal of hepatology 62 (4), 956-967, 2015 | 516 | 2015 |
| Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study WJ Lammers, HR van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ... Gastroenterology 147 (6), 1338-1349. e5, 2014 | 516 | 2014 |
| Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b EHCJ Buster, HJ Flink, Y Cakaloglu, K Simon, J Trojan, F Tabak, TMK So, ... Gastroenterology 135 (2), 459-467, 2008 | 516 | 2008 |
| Factors that predict response of patients with hepatitis B e antigen–Positive chronic hepatitis B to peginterferon-alfa EHCJ Buster, BE Hansen, GKK Lau, T Piratvisuth, S Zeuzem, ... Gastroenterology 137 (6), 2002-2009, 2009 | 501 | 2009 |
| Long‐term follow‐up of alpha‐interferon treatment of patients with chronic hepatitis B M van Zonneveld, P Honkoop, BE Hansen, HGM Niesters, SD Murad, ... Hepatology 39 (3), 804-810, 2004 | 490 | 2004 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 473 | 2017 |
| PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 64 (4), 800-806, 2016 | 445 | 2016 |
| Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ... Gastroenterology 149 (7), 1804-1812. e4, 2015 | 444 | 2015 |
| Prediction of sustained response to peginterferon alfa‐2b for hepatitis B e antigen–positive chronic hepatitis B using on‐treatment hepatitis B surface antigen decline MJ Sonneveld, V Rijckborst, CAB Boucher, BE Hansen, HLA Janssen Hepatology 52 (4), 1251-1257, 2010 | 411 | 2010 |
| Determinants of survival and the effect of portosystemic shunting in patients with Budd‐Chiari syndrome SD Murad, DC Valla, PC De Groen, G Zeitoun, JAM Hopmans, ... Hepatology 39 (2), 500-508, 2004 | 404 | 2004 |
| Extrahepatic portal vein thrombosis: aetiology and determinants of survival HLA Janssen, A Wijnhoud, EB Haagsma, SHM Van Uum, ... Gut 49 (5), 720-724, 2001 | 391 | 2001 |
| Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype HJ Flink, M Van Zonneveld, BE Hansen, RA De Man, SW Schalm, ... Official journal of the American College of Gastroenterology| ACG 101 (2 …, 2006 | 378 | 2006 |
| Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus BJ Veldt, W Chen, EJ Heathcote, H Wedemeyer, J Reichen, WP Hofmann, ... Hepatology 47 (6), 1856-1862, 2008 | 366 | 2008 |
| Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study EM Koehler, EPC Plompen, JNL Schouten, BE Hansen, SD Murad, ... Hepatology 63 (1), 138-147, 2016 | 350 | 2016 |
| Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels V Rijckborst, BE Hansen, Y Cakaloglu, P Ferenci, F Tabak, M Akdogan, ... Hepatology 52 (2), 454-461, 2010 | 337 | 2010 |
